Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Therapeutics

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLINTHERA.2007.03.018PMID 17617280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rationale for Fixed-Dose Combinations in the Treatment of Hypertension

  2012cited by this paper
• Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients

  2007cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension: United States National Health and Nutrition Examination Survey 2001–2002

  2006cited by this paper
• Long-term adherence with cardiovascular drug regimens.

  2006cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003–2004 Secondary Prevention Trials

  2005cited by this paper
• Adherence to medication.

  2005cited by this paper
• Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

  2005cited by this paper
• Hypertension Treatment and Control in Five European Countries, Canada, and the United States

  2004cited by this paper
• Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.

  2004cited by this paper
• The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide

  2004cited by this paper
• Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.

  2004cited by this paper
• The Role of Existing and Newer Calcium Channel Blockers in the Treatment of Hypertension

  2004cited by this paper
• Hypertension management in adults with diabetes.

  2004cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Achieving Goal Blood Pressure in Patients With Type 2 Diabetes: Conventional Versus Fixed‐Dose Combination Approaches

  2003cited by this paper
• Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

  2003cited by this paper
• Evolution of calcium antagonists: Past, present, and future

  2003cited by this paper
• Creating a Combination Antihypertensive Regimen: What Does the Research Show?

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Is fixed combination therapy appropriate for initial hypertension treatment?

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Low-dose combination therapy: an important first-line treatment in the management of hypertension.

  2001cited by this paper
• Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence?

  2000cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

  1997cited by this paper
• Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

  1996cited by this paper
• Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.

  1996cited by this paper
• Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

  1995cited by this paper
• Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype

  1993cited by this paper

• Closing gaps in blood pressure control: a look at two major approaches

  2025cites this paper
• Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects

  2025cites this paper
• A systematic review of commencing full-dose antihypertensives in newly diagnosed hypertension

  2025cites this paper
• Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study

  2025cites this paper
• Study of the effect of different drug treatment strategies in patients with hypertension

  2024cites this paper
• Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure.

  2024cites this paper
• Personalized Antihypertensive Treatment Optimization With Smartphone‐Enabled Remote Precision Dosing of Amlodipine During the COVID‐19 Pandemic (PERSONAL‐CovidBP Trial)

  2024cites this paper
• Вивчення впливу різних стратегій медикаментозного лікування у пацієнтів із артеріальною гіпертензією

  2024cites this paper
• The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.

  2024cites this paper
• Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers

  2024cites this paper
• Insight into the dissolution behavior of valsartan (form E) in twelve pure solvents: Solubility, modelling and molecular simulation

  2024cites this paper
• A Basic Review on Hypertension, its Non-Pharmacological and Pharmacological Treatment

  2024cites this paper
• New Insights into the Nephroprotective Potential of Lercanidipine

  2023cites this paper
• Effect of fixed-dose combination Amlodipine/Valsartan in comparison to two Drug combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure.

  2023cites this paper
• Efficacy and safety of single pill combination of amlodipine and valsartan in hypertensive Saudi patients.

  2023cites this paper
• Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension

  2023cites this paper
• Прихильність до терапії у хворих високого серцево-судинного ризику в Україні: пацієнт-орієнтовані причини і можливості її поліпшення

  2023cites this paper
• Effects of Qingda granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial

  2023cites this paper
• A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

  2022cites this paper
• Design of clinical development programs

  2022cites this paper
• Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension

  2021cites this paper
• Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis

  2021cites this paper
• Fixed-dose-combinations of Olmesartan / Amlodipine and Valsartan / Amlodipine for Treatment of Essential Hypertension : A Network Meta-analysis

  2020cites this paper
• Reduced Lymphatic Function Predisposes to Calcium Channel Blocker Edema: A Randomized Placebo-Controlled Clinical Trial

  2020cites this paper
• KOMBINASI AMLODIPIN MICARDIS; STUDI PERSPEKTIF EFEKTIVITAS BIAYA PENGOBATAN HIPERTENSI

  2020cites this paper
• Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial

  2020cites this paper
• Amlodipine/Valsartan (Avsar®): Efficacy in Hypertensive Patients - A Real World Observational Study (ALERT)

  2020cites this paper
• Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting.

  2019cites this paper
• Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials.

  2019cites this paper
• The effect of lercanidipine or lercanidipine/enalapril combination on blood pressure in treatment-naïve patients with stage 1 or 2 systolic hypertension

  2019cites this paper
• China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III)

  2019cites this paper
• Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies

  2018cites this paper
• Comparative in vitro evaluation of some commercial brands of valsartan tablets marketed in Bangladesh

  2018cites this paper
• Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure

  2018cites this paper
• 27 – Use of Combination Therapies

  2018cites this paper
• An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.

  2018cites this paper
• ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF AMLODIPINE IN HUMAN PLASMA USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY/MASS SPECTROMETRY

  2018cites this paper
• Amlodipine in the Era of New Generation Calcium Channel Blockers.

  2018cites this paper
• Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials

  2018cites this paper
• Combination therapies for hypertension – why we need to look beyond RAS blockers

  2018cites this paper
• Clinical Utility of Amlodipine/Valsartan Fixed-Dose Combination in the Management of Hypertension in Chinese Patients

  2017cites this paper
• Monotherapy versus Polytherapy in Patients with Hypertension

  2017cites this paper
• Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study

  2017cites this paper
• Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension

  2017cites this paper
• Prediction of factors affecting amlodipine induced pedal edema and its classification

  2017cites this paper
• Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses

  2016cites this paper
• The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension.

  2016cites this paper
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.

  2016cites this paper
• Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union

  2016cites this paper
• Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study

  2016cites this paper
• Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy

  2016cites this paper
• Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial

  2016cites this paper
• Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial

  2016cites this paper
• Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.

  2015cites this paper
• S 20 Hypertension and valsartan

  2015cites this paper
• Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine

  2015cites this paper
• Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview.

  2015cites this paper
• Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients

  2015cites this paper
• Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.

  2015cites this paper
• Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study.

  2015cites this paper
• Hypertension and valsartan.

  2015cites this paper
• Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.

  2015cites this paper
• Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases

  2015cites this paper
• A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.

  2015influential citation
• Efficacy and Safety of Valsartan/Amlodipine Single-Pill Combination in 11,422 Chinese Patients with Hypertension: an Observational Study

  2014cites this paper
• Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results

  2014cites this paper
• Pharmacokinetics, Tolerability, and Safety of the Single Oral Administration of AGSAV301 vs Exforge: A Randomized Crossover Study of Healthy Male Volunteers

  2014cites this paper
• Daytime Systolic Ambulatory Blood Pressure With a Two‐Step Switch From Candesartan to Olmesartan Monotherapy and the Fixed‐Dose Combination of Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐2)

  2014cites this paper
• Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy

  2014cites this paper
• [Fixed irbesartan/amlodipine combination: efficacy and safety of the use of four dosing regimens in patients with arterial hypertension].

  2014cites this paper
• Indirect treatment comparison between fixed‐dose‐combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control

  2014cites this paper
• A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients

  2014cites this paper
• Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone

  2014cites this paper
• Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study

  2014cites this paper
• Human lymphatic vessel contractile activity is inhibited in vitro but not in vivo by the calcium channel blocker nifedipine

  2014cites this paper
• A guide for easy- and difficult-to-treat hypertension.

  2014cites this paper
• Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan

  2014cites this paper
• Evaluation of Therapeutic Differences of Angiotensin II Receptor Blockers and Calcium Channel Blockers Among Hypertensive Patients Classified by Oriental Traditional Way

  2014cites this paper
• The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

  2014influential citation
• Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW) Hipertansif hastalarda valsartan/amlodipin tek tablet kombinasyonunun etkinlik ve güvenliliği (PEAK LOW)

  2014cites this paper
• Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW).

  2014cites this paper
• Azilsartan, Aliskiren, and Combination Antihypertensives Utilizing Renin–Angiotensin–Aldosterone System Antagonists

  2014influential citation
• SIGNIFICANCE OF NANOPARTICLE DRUG DELIVERY SYSTEM THAN CONVENTIONAL DRUG DELIVERY SYSTEM OF ANTIHYPERTEENSIVE DRUGS

  2014cites this paper
• A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.

  2014cites this paper
• The Effects of Telmisartan and Amlodipine in Treatment-Naïve and Previously Treated Hypertensive Patients: A Subanalysis from a 4 × 4 Factorial Design Study

  2013cites this paper
• Combination therapy for hypertension 2013: an update.

  2013cites this paper
• Treatment algorithms for hypertension: a practical approach

  2013cites this paper
• Amlodipine/valsartan 5/160 mg versus valsartan 160 mg in Chinese hypertensives.

  2013cites this paper
• Meta-analysis of three observational studies of amlodipine/valsartan in hypertensive patients with additional risk factors

  2013cites this paper
• Design of Clinical Development Programs

  2013cites this paper
• Daytime Systolic Ambulatory Blood Pressure With a Direct Switch Between Candesartan Monotherapy and the Fixed‐Dose Combination Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐1)

  2013cites this paper
• [Cost-effectiveness analysis of fixed dose antihypertensive drugs].

  2013influential citation
• COMBI NATION TECHNOLOGY FOR TREATMENT OF HYPERTENSION : A REVIEW

  2013cites this paper
• Determination of Amlodipine in Human Plasma by LC-MS/MS and Its Bioequivalence Study in Healthy Chinese Subjects

  2013cites this paper
• Optimization and validation of a MEKC method assisted by Box–Behnken Design for fast and simultaneous determination of nitrendipine and atenolol in new antihypertensive combination tablets

  2013cites this paper
• Diferencias y similitudes entre los bloqueadores de los receptores del calcio (antagonistas del calcio)

  2013cites this paper
• Combination Therapy in Hypertension

  2013cites this paper
• Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

  2013cites this paper
• Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

  2013cites this paper
• COMBINATION TECHNOLOGY FOR TREATMENT OF HYPERTENSION: A REVIEW

  2013cites this paper